Status:
UNKNOWN
Pharmacology of Immunosuppressants Following Heart Transplantation
Lead Sponsor:
Nigel E. Drury
Conditions:
Heart Transplantation
Eligibility:
All Genders
18+ years
Brief Summary
The ongoing success of transplantation is largely due to the development of drugs to stop the patient's body from rejecting the new organ. In addition to steroids, two main types of drug are used to s...
Eligibility Criteria
Inclusion
- All patients undergoing heart transplantation
Exclusion
- Decline participation
- Previous transplantation of another organ and already receiving chronic immunosuppressive therapy
Key Trial Info
Start Date :
November 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT01423552
Start Date
November 1 2011
Last Update
August 26 2011
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Basil Hetzel Institute for Medical Research
Adelaide, South Australia, Australia
2
Queen Elizabeth Hospital Birmingham
Birmingham, West Midlands, United Kingdom, B15 2WB